Viking Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2015 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Viking Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2015 to Q3 2024.
  • Viking Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 15, 2024 was 111M shares, a 11.4% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 111M +11.4M +11.4% Oct 15, 2024 10-Q 2024-10-23
Q2 2024 111M +10.8M +10.8% Jul 15, 2024 10-Q 2024-07-24
Q1 2024 110M +10.7M +10.7% Apr 15, 2024 10-Q 2024-04-25
Q4 2023 100M +22.1M +28.1% Jan 31, 2024 10-K 2024-02-07
Q3 2023 100M +23.3M +30.4% Oct 15, 2023 10-Q 2023-10-25
Q2 2023 100M +23.3M +30.4% Jul 15, 2023 10-Q 2023-07-26
Q1 2023 99.6M +22.2M +28.7% Apr 15, 2023 10-Q 2023-04-26
Q4 2022 78.4M +55.6K +0.07% Jan 31, 2023 10-K 2023-02-10
Q3 2022 76.7M -1.55M -1.98% Oct 15, 2022 10-Q 2022-10-26
Q2 2022 76.7M -1.5M -1.92% Jul 15, 2022 10-Q 2022-07-27
Q1 2022 77.4M -726K -0.93% Apr 15, 2022 10-Q 2022-04-27
Q4 2021 78.4M +4.23M +5.71% Jan 31, 2022 10-K 2022-02-09
Q3 2021 78.2M +5.28M +7.24% Oct 15, 2021 10-Q 2021-11-03
Q2 2021 78.2M +5.43M +7.47% Jul 15, 2021 10-Q 2021-07-28
Q1 2021 78.1M +5.5M +7.58% Apr 15, 2021 10-Q 2021-04-28
Q4 2020 74.1M +1.57M +2.16% Jan 31, 2021 10-K 2021-02-17
Q3 2020 73M +688K +0.95% Oct 15, 2020 10-Q 2020-10-28
Q2 2020 72.8M +548K +0.76% Jul 15, 2020 10-Q 2020-07-29
Q1 2020 72.6M +549K +0.76% Apr 15, 2020 10-Q 2020-04-30
Q4 2019 72.6M Jan 31, 2020 10-K 2020-02-26
Q3 2019 72.3M +804K +1.13% Oct 31, 2019 10-Q 2019-11-05
Q2 2019 72.2M +11.6M +19% Jul 31, 2019 10-Q 2019-08-01
Q1 2019 72M +21.1M +41.5% Apr 30, 2019 10-Q 2019-05-02
Q3 2018 71.5M +43M +151% Oct 31, 2018 10-Q 2018-11-07
Q2 2018 60.7M +33M +119% Jul 31, 2018 10-Q 2018-08-09
Q1 2018 50.9M +27M +113% Apr 30, 2018 10-Q 2018-05-09
Q3 2017 28.5M +8.33M +41.3% Oct 31, 2017 10-Q 2017-11-08
Q2 2017 27.7M +8.42M +43.7% Jul 31, 2017 10-Q 2017-08-09
Q1 2017 23.9M +4.66M +24.2% Apr 30, 2017 10-Q 2017-05-10
Q3 2016 20.2M +10.5M +108% Oct 31, 2016 10-Q 2016-11-10
Q2 2016 19.3M +9.49M +97% Jul 31, 2016 10-Q 2016-08-11
Q1 2016 19.3M Apr 29, 2016 10-Q 2016-05-10
Q3 2015 9.68M Nov 2, 2015 10-Q 2015-11-05
Q2 2015 9.78M Jun 10, 2015 10-Q 2015-06-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.